Coakley Kathryn E, Douglas Teresa D, Goodman Michael, Ramakrishnan Usha, Dobrowolski Steven F, Singh Rani H
Doctoral Program in Nutrition and Health Sciences, Laney Graduate School, Emory University, Atlanta, GA, USA.
, 2165 North Decatur Road, Decatur, GA, 30033, USA.
J Inherit Metab Dis. 2016 May;39(3):363-372. doi: 10.1007/s10545-015-9910-0. Epub 2016 Feb 16.
Phenylalanine hydroxylase (PAH) deficiency is an inherited metabolic disorder requiring life-long restriction of dietary protein and phenylalanine-free medical food. Low bone mineral density (BMD) is reported, but factors associated with BMD Z-score (standard deviations from normal) are unknown. We examined associations between clinical and dietary parameters and total BMD Z-score in PAH deficiency patients, and developed models to predict Z-score. Data collected from patients >4 years of age (n = 88; mean age = 18.8 y; 61 % female) included demographic, clinical, laboratory, and dietary intakes. Adjusted Spearman's correlation coefficients were calculated between parameters and TBMD Z-score, measured by dual energy x-ray absorptiometry (DXA). Parameters approaching significance (p-value < 0.10) were candidate predictors for four linear regression models predicting TBMD Z-score. To validate, model-predicted Z-scores were compared to DXA Z-scores. Mean TBMD Z-score was -0.326; 18 (20.4 %) had Z-score < -1. Z-scores were positively correlated with dietary vitamin D, calcium, and medical food intake and compliance with prescription, and negatively with dietary carbohydrate, sugar, caffeine intake, glycemic load, and prescribed medical food (grams protein/day; p-value < 0.05). The best model included medical food compliance, medical food intake, caffeine intake, and bone-specific alkaline phosphatase (r-square = 0.364). This model predicted Z-score category [normal or low (<-1)] with sensitivity = 66.7 %, likelihood ratio = 14.7, and AUC = 0.83 compared to DXA Z-score. No subjects had low BMD for chronological age (Z-score ≤ -2). Compliance with medical food prescription was the strongest predictor of TBMD Z-score. One model, if validated in a separate sample of patients with more cases of low BMD, showed potential to estimate TBMD Z-score using routine clinical patient parameters.
苯丙氨酸羟化酶(PAH)缺乏症是一种遗传性代谢紊乱疾病,需要终身限制膳食蛋白质摄入并食用不含苯丙氨酸的医用食品。有报道称患者骨矿物质密度(BMD)较低,但与BMD Z评分(相对于正常水平的标准差)相关的因素尚不清楚。我们研究了PAH缺乏症患者的临床和饮食参数与总BMD Z评分之间的关联,并建立了预测Z评分的模型。收集了年龄大于4岁患者(n = 88;平均年龄 = 18.8岁;61%为女性)的人口统计学、临床、实验室和饮食摄入数据。通过双能X线吸收法(DXA)测量参数与总骨密度(TBMD)Z评分之间的校正Spearman相关系数。接近显著水平(p值 < 0.10)的参数是预测TBMD Z评分的四个线性回归模型的候选预测因子。为进行验证,将模型预测的Z评分与DXA Z评分进行比较。平均TBMD Z评分为 -0.326;18例(20.4%)的Z评分 < -1。Z评分与膳食维生素D、钙、医用食品摄入量及医嘱依从性呈正相关,与膳食碳水化合物、糖、咖啡因摄入量、血糖负荷及规定的医用食品(每日蛋白质克数)呈负相关(p值 < 0.05)。最佳模型包括医用食品依从性、医用食品摄入量、咖啡因摄入量和骨特异性碱性磷酸酶(决定系数 = 0.364)。与DXA Z评分相比,该模型预测Z评分类别[正常或低(< -1)]的敏感度为66.7%,似然比为14.7,曲线下面积(AUC)为0.83。按实际年龄计算,没有受试者的骨密度低(Z评分≤ -2)。医用食品处方的依从性是TBMD Z评分的最强预测因子。如果在另一组有更多低骨密度病例的患者样本中得到验证,一个模型显示出利用常规临床患者参数估计TBMD Z评分的潜力。